NEUVOGEN Announces Appointment of Chief Financial Officer
/PRNewswire/ -- NEUVOGEN, an immunoncology company, is pleased to announce the appointment of George Montgomery as Chief Financial Officer. He will oversee...
Source: prnewswire.com
Page 5 - Lumen Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lumen Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lumen Bioscience Today - Breaking & Trending Today
Novo Nordisk A/S - Consensus Indicates Potential -.1% Downside - DirectorsTalk Interviews
Novo Nordisk A/S - Consensus Indicates Potential -.1% Downside
Source: directorstalkinterviews.com
Brandessence Market Research And Consulting Private Limited: At 4.5% CAGR, Microalgae Market is Expected to Reach 4996.8 Million by 2027, says Brandessence Market Research
LONDON, Dec. 14, 2021 /PRNewswire/ -- According to Brandessence Market research, the tremendous promise of microalgae biofuel, rich potential as a nutraceutical is likely to drive a robust CAGR-driven
Source: finanznachrichten.de
At 4.5% CAGR, Microalgae Market is Expected to Reach 4996.8 Million by 2027, says Brandessence Market Research
/PRNewswire/ -- According to Brandessence Market research, the tremendous promise of microalgae biofuel, rich potential as a nutraceutical is likely to drive a...
Source: prnewswire.com
Global Plant-based Vaccines Market to Surpass US$ 584.1 Million by 2028, Says Coherent Market Insights (CMI)
: Key trends in the market include increasing research and development activities, increasing cases of influenza, ongoing clinical trials on plant-based vaccine, inorganic activities such as collaborations by the market players, and others. Increasing number of research and development activities for improving the effectiveness of plant-based vaccines is expected to bolster growth of the plant-based vaccines market. For instance, on November 10, 2020, Medicago Inc. started conducting clinical trials for the production of plant-based COVID-19 vaccine. The company is planning to initiate Phase...
Source: benzinga.com